Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors

被引：0
|
作者：
Boussion, H. [1 ]
Hammel, P. [2 ]
机构：
[1] AERIO, Tokyo, Japan
[2] Hop Beaujon, Clichy, France
来源：
ONCOLOGIE | 2015年 / 17卷 / 1-2期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：59 / 60
页数：2
相关论文
共 50 条
  • [41] Long-acting lanreotide in the treatment of neuroendocrine tumors (NETs)
    Antonuzzo, A
    Ricci, S
    Galli, L
    Conte, PF
    ANNALS OF ONCOLOGY, 1998, 9 : 175 - 175
  • [42] Inhibition of glucose metabolism in neuroendocrine tumors by lanreotide, sunitinib, and rapamycin
    Rubinek, Tami
    Shabtay-Orbach, Ayelet
    Hesin, Arkadi
    Rubinstein, Tammi
    Wolf, Ido
    CANCER RESEARCH, 2016, 76
  • [43] Long-acting release lanreotide in the treatment of neuroendocrine tumors
    Ruszniewski, P
    ANNALES D ENDOCRINOLOGIE, 1998, 59 : 51 - 52
  • [44] Nutritional assessment for predicting clinical evolution in gastro-enteropancreatic neuroendocrine tumors
    Alzas-Teomiro, C. M.
    Leon-Idougourram, S.
    Alcantara-Laguna, M.
    Molina-Puertas, M. J.
    Galvez-Moreno, M. A.
    Herrera-Martinez, A. D.
    JOURNAL OF NEUROENDOCRINOLOGY, 2021, 33 : 44 - 44
  • [45] Lanreotide autogel/depot in advanced enteropancreatic neuroendocrine tumours: final results of the CLARINET open-label extension study
    Martyn E. Caplin
    Marianne Pavel
    Alexandria T. Phan
    Jarosław B. Ćwikła
    Eva Sedláčková
    Xuan-Mai Truong Thanh
    Edward M. Wolin
    Philippe Ruszniewski
    Endocrine, 2021, 71 : 502 - 513
  • [46] Molecular Targeted Therapy in Enteropancreatic Neuroendocrine Tumors: From Biology to Clinical Practice
    Fazio, N.
    Scarpa, A.
    Falconi, M.
    CURRENT MEDICINAL CHEMISTRY, 2014, 21 (08) : 1017 - 1025
  • [47] Imaging of Metastatic Neuroendocrine Tumors
    Shore, K.
    Jagannathan, J.
    Ramaiya, N.
    Shinagare, A.
    Van Den Abbeele, A.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2010, 194 (05)
  • [48] Prospective, randomized, multicenter trial on the antiproliferative effect of lanreotide, interferon alfa, and their combination for therapy of metastatic neuroendocrine gastroenteropancreatic tumors
    Fazio, N
    Oberg, K
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (03) : 573 - 574
  • [49] Wirksamkeit von Lanreotid bei metastasiertem neuroendokrinen Tumor des GastrointestinaltraktsEfficacy of lanreotide in metastatic neuroendocrine tumors of the gastrointestinal tract
    F. Schmitz
    Der Gastroenterologe, 2014, 9 (5): : 470 - 472
  • [50] Comparing the Cost of Treatment with Octreotide Long-Acting Release versus Lanreotide in Patients with Metastatic Gastrointestinal Neuroendocrine Tumors
    Ayyagari, Rajeev
    Neary, Maureen
    Li, Shang
    Rokito, Ariel
    Yang, Hongbo
    Xie, Jipan
    Benson, Al B., III
    AMERICAN HEALTH AND DRUG BENEFITS, 2017, 10 (08): : 408 - 415
12345